Degayo, Jairah Dawn D.
HRN: 27-22-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2025
CEFUROXIME 750MG (VIAL)
11/14/2025
11/21/2025
IV
320mg
Q8
Pcap C With Hrad
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes